Literature DB >> 32229156

Host Defense Peptide RNase 7 Is Down-regulated in the Skin of Diabetic Patients with or without Chronic Ulcers, and its Expression is Altered with Metformin.

Adrian Rodríguez-Carlos1, Valentin Trujillo2, Irma Gonzalez-Curiel3, Sara Marin-Luevano4, Flor Torres-Juarez4, Alan Santos-Mena4, Cesar Rivas-Santiago5, Jose A Enciso-Moreno4, Veronica Zaga-Clavellina6, Bruno Rivas-Santiago7.   

Abstract

BACKGROUND: Diabetic foot ulcers (DFUs) are one of the main complications in patients with type 2 diabetes mellitus (DM2), previous studies have reported that DM2 patients have lower production of host defense peptides (HDP). AIM OF THE STUDY: To investigate the expression of RNase 7, cathelicidin, HBD-2, and psoriasin in biopsies obtained from DM2 patients with or without DFU.
METHODS: Biopsies from DFU patients grade 3 according to Wagner's classification, from diabetic patients without ulcer and from healthy donors were obtained. qPCR, immunohistochemistry and cell line cultures were performed. To assess whether L-isoleucine, calcitriol, phenyl butyrate, metformin, glyburide or insulin induced RNase 7, keratinocytes were stimulated, and RNase 7 expression was evaluated.
RESULTS: Our data showed that RNase 7 levels were decreased in both diabetic groups when were compared with skin from healthy donors. Since most of the DM2 patients are treated with drugs to reduce glycemia, we investigated whether glyburide, metformin or insulin were able to induce any change regarding RNase 7 production. Results showed that metformin reduces the expression of RNase 7 in in vitro treated keratinocytes, suggesting that the chronic use of metformin should be evaluated in DFU patients, whereas calcitriol, phenyl butyrate and L-isoleucine did not increase the RNase 7 production.
CONCLUSIONS: Due RNase 7 has antimicrobial activity, its downregulation can make prone to DM2 patients to develop infections and impaired wound healing.
Copyright © 2020 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptides; Diabetes mellitus; Diabetic foot ulcers; Metformin; RNase 7; Wound healing

Year:  2020        PMID: 32229156     DOI: 10.1016/j.arcmed.2020.03.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  3 in total

1.  RNase 7 Inhibits Uropathogenic Escherichia coli-Induced Inflammation in Bladder Cells under a High-Glucose Environment by Regulating the JAK/STAT Signaling Pathway.

Authors:  Chen-Hsun Ho; Pin-Wen Liao; Chia-Kwung Fan; Shih-Ping Liu; Po-Ching Cheng
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 5.923

Review 2.  The role and mechanism of butyrate in the prevention and treatment of diabetic kidney disease.

Authors:  Xi Cheng; Tingting Zhou; Yanqiu He; Yumei Xie; Yong Xu; Wei Huang
Journal:  Front Microbiol       Date:  2022-08-09       Impact factor: 6.064

3.  Gene losses in the common vampire bat illuminate molecular adaptations to blood feeding.

Authors:  Moritz Blumer; Tom Brown; Mariella Bontempo Freitas; Ana Luiza Destro; Juraci A Oliveira; Ariadna E Morales; Tilman Schell; Carola Greve; Martin Pippel; David Jebb; Nikolai Hecker; Alexis-Walid Ahmed; Bogdan M Kirilenko; Maddy Foote; Axel Janke; Burton K Lim; Michael Hiller
Journal:  Sci Adv       Date:  2022-03-25       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.